Product Information
AMLODIPINE-VALSARTAN 10-160 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3297 per EA under NDC 33342028010. Its NADAC has been published 83 times since Mar 5, 2025.
FDA first approved this application on Oct 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 160 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342028010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA207292FDA Approved
10/11/2024
TE Code
AB
On Market Since
10/16/2024
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 10-160 MG has been published 83 times since Mar 5, 2025, and over the history we have for it it has declined 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3297 per EA |
|---|---|
| All-time high | $0.5237 (Jul 16, 2025) |
| All-time low | $0.3297 (Sep 23, 2026) |
| 52-week high | $0.5131 |
| 52-week low | $0.3297 |
| Median price | $0.5060 |
| Average price | $0.4832 |
| Largest weekly change | -12.3% (Jul 22, 2026) |
| Weeks tracked | 83 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine and valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 10-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-160 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.3297 per EA (NDC 33342028010), effective Sep 30, 2026.
How has the price of AMLODIPINE-VALSARTAN 10-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has declined 36.4%. It has been tracked across 83 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-160 MG?
Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has ranged from a low of $0.3297 (Sep 23, 2026) to a high of $0.5237 (Jul 16, 2025), with a median of $0.5060 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-160 MG?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 10-160 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-VALSARTAN 10-160 MG?
AMLODIPINE-VALSARTAN 10-160 MG (NDC 33342028010) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.